Systematic review of efficacy of direct oral anticoagulants and vitamin K antagonists in left ventricular thrombus
ConclusionsCompared with VKAs, DOACs significantly reduce the risk of bleeding events and stroke in LVT patients, but mortality was similar in both groups. The advantages are apparent not only in patients belonging to the predominantly white residential areas such as North American and European regions but also in patients with LVT due to IHD. DOACs show promising effects in treating LVT compared with VKAs.
Source: ESC Heart Failure - Category: Cardiology Authors: Lei Huang,
Yuan Tan,
Yilong Pan Tags: Original Article Source Type: research
More News: Bleeding | Cardiology | Databases & Libraries | Heart | Heart Disease | Heart Failure | Ischemic Stroke | Science | Statistics | Stroke | Study | Thrombosis | USA Health | Vitamin K | Vitamins